Table 2.
Changes in risk reduction behaviors from before to after web-based intervention in melanoma survivors
| Outcomes | Baseline
|
Follow-up
|
||
|---|---|---|---|---|
| I | C | I | C | |
| Screening behavior | Once/more than once (%) | Once/more than once (%) | Once/more than once (%) | Once/more than once (%) |
| The front of you from the waist up | 111 (70.70) | 116 (74.36) | 100 (70.92) | 107 (73.79) |
| The front of your thighs and legs | 108 (68.79) | 114 (73.08) | 101 (71.63) | 109 (75.17) |
| The bottom of your feet** | 56 (35.67) | 62 (39.74) | 91 (64.68) | 55 (37.93) |
| Your calves | 92 (58.60) | 107 (68.59) | 93 (65.96) | 99 (68.28) |
| The back of your thighs and legs | 77 (49.04) | 87 (55.77) | 76 (53.90) | 79 (54.48) |
| Your buttocks and lower part of your back** | 72 (45.86) | 81 (51.92) | 92 (66.81) | 77 (53.10) |
| Your upper back | 90 (57.32) | 100 (64.10) | 85 (60.28) | 92 (63.45) |
| Self screening examination | Yes (%) | Yes (%) | Yes (%) | Yes (%) |
| Do a thorough skin examination** | 41 (26.11) | 27 (17.31) | 54 (37.02) | 24 (16.55) |
| Provider screening | Yes (%) | Yes (%) | Yes (%) | Yes (%) |
| Check all of your skin, by asking you to take your clothes off | 142 (96.60) | 133 (93.01) | 132 (96.35) | 127 (96.21) |
| Sun protection behaviors | Adherent (%) | Adherent (%) | Adherent (%) | Adherent (%) |
| Wear a long-sleeved shirt or blouse* | 117 (74.52) | 109 (69.87) | 141 (90.85) | (82.76) |
| Wear long pants or long skirt | 138 (87.90) | 131 (83.97) | 126 (89.36) | 127 (87.59) |
| Wear sunscreen SPF 15+ | 78 (49.68) | 82 (52.56) | 96 (66.23) | 80 (55.17) |
| Wear something on your head* (hat, cap, scarf) | 59 (37.58) | 68 (43.59) | 91 (62.55) | 65 (44.83) |
| Wear a hat with a brim at least 2.5 in wide all the way around | 26 (16.56) | 33 (21.15) | 26 (18.44) | 28 (19.31) |
| Wear sunglasses** | 80 (50.96) | 83 (53.21) | 102 (70.35) | 73 (50.34) |
| Stay in available shade** | 68 (43.31) | 70 (44.87) | 91 (62.55) | 57 (39.31) |
| Avoid outdoors when the sun is strongest** | 37 (23.57) | 42 (26.92) | 70 (48.37) | 38 (26.21) |
*
p<0.05. Significant change from baseline to follow-up in intervention group
**
p<0.01. Significant change from baseline to follow-up in intervention group